These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3942055)

  • 1. Relation of serum reverse T3 to amiodarone antiarrhythmic efficacy and toxicity.
    Kerin NZ; Blevins RD; Benaderet D; Faitel K; Jarandilla R; Garfinkel C; Klein S; Rubenfire M
    Am J Cardiol; 1986 Jan; 57(1):128-30. PubMed ID: 3942055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic significance of serum reverse T3 levels during amiodarone treatment: a potential method for monitoring chronic drug therapy.
    Nademanee K; Singh BN; Hendrickson JA; Reed AW; Melmed S; Hershman J
    Circulation; 1982 Jul; 66(1):202-11. PubMed ID: 7083508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amiodarone and thyroid function: clinical implications during antiarrhythmic therapy.
    Singh BN; Nademanee K
    Am Heart J; 1983 Oct; 106(4 Pt 2):857-69. PubMed ID: 6412534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum reverse T3 and amiodarone efficacy.
    Haberman RJ; Ladenson PW; Griffith LS; Veltri EP
    Clin Cardiol; 1989 Mar; 12(3):140-4. PubMed ID: 2466595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The correlation of serum amiodarone levels with abnormalities in the metabolism of thyroxine.
    Anastasiou-Nana M; Koutras DA; Levis G; Souvatzoglou A; Boukis MA; Moulopoulos SD
    J Endocrinol Invest; 1984 Aug; 7(4):405-7. PubMed ID: 6501809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of Holter monitoring in identifying risk for sustained ventricular arrhythmia recurrence on amiodarone.
    Marchlinski FE; Buxton AE; Flores BT; Doherty JU; Waxman HL; Josephson ME
    Am J Cardiol; 1985 Mar; 55(6):709-12. PubMed ID: 3976513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oral triiodothyronine during amiodarone treatment for ventricular premature complexes.
    Polikar R; Goy JJ; Schlapfer J; Lemarchand-Beraud T; Biollaz J; Magnenat P; Nicod P
    Am J Cardiol; 1986 Nov; 58(10):987-91. PubMed ID: 2430444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term clinical outcome of ventricular tachycardia or fibrillation treated with amiodarone.
    McGovern B; Garan H; Malacoff RF; DiMarco JP; Grant G; Sellers TD; Ruskin JN
    Am J Cardiol; 1984 Jun; 53(11):1558-63. PubMed ID: 6731300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Usefulness of the reverse T3 (rT3) determination in patients under chronic treatment with amiodarone].
    de los Angeles Valenzuela M; Bianchi C; Meruane J; Pineda G
    Rev Med Chil; 1984 Mar; 112(3):228-32. PubMed ID: 6473963
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of malignant ventricular tachyarrhythmia with amiodarone: comparison of empirical administration and administration guided by Holter or ventricular stimulation. Results of the parallel test].
    Raviele A; Di Pede F; Gasparini G; Zanocco A; Delise P; Bonso A; D'Este D; Piccolo E
    G Ital Cardiol; 1991 Mar; 21(3):259-69. PubMed ID: 1894120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of amiodarone during long-term treatment of malignant ventricular arrhythmias in patients with chronic chagasic myocarditis.
    Chiale PA; Halpern MS; Nau GJ; Tambussi AM; Przybylski J; Lázzari JO; Elizari MV; Rosenbaum MB
    Am Heart J; 1984 Apr; 107(4):656-65. PubMed ID: 6702559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of Holter monitoring in predicting long-term efficacy and inefficacy of amiodarone used alone and in combination with class 1A antiarrhythmic agents in patients with ventricular tachycardia.
    Kim SG; Felder SD; Figura I; Johnston DR; Waspe LE; Fisher JD
    J Am Coll Cardiol; 1987 Jan; 9(1):169-74. PubMed ID: 3794093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of amiodarone during long-term treatment of potentially dangerous ventricular arrhythmias in patients with chronic stable ischemic heart disease.
    Kaski JC; Girotti LA; Elizari MV; Lázzari JO; Goldbarg A; Tambussi A; Rosenbaum MB
    Am Heart J; 1984 Apr; 107(4):648-55. PubMed ID: 6702558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amiodarone and sustained ventricular arrhythmias: statistical evidence of drug effectiveness.
    Flaker GC; Alpert MA; Webel RR; Ruder MA; Sanfelippo JF; Tsutakawa RK
    Am Heart J; 1985 Aug; 110(2):371-6. PubMed ID: 4025112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of programmed stimulation and Holter monitoring for predicting long-term efficacy and inefficacy of amiodarone used alone or in combination with a class 1A antiarrhythmic agent in patients with ventricular tachyarrhythmia.
    Kim SG; Felder SD; Figura I; Johnston DR; Waspe LE; Fisher JD
    J Am Coll Cardiol; 1987 Feb; 9(2):398-404. PubMed ID: 3805529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperthyroxinemia with bradycardia and normal thyrotropin secretion after chronic amiodarone administration.
    Melmed S; Nademanee K; Reed AW; Hendrickson JA; Singh BN; Hershman JM
    J Clin Endocrinol Metab; 1981 Nov; 53(5):997-1001. PubMed ID: 7287882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interrelationships between serum levels of amiodarone, desethylamiodarone, reverse T3 and the QT interval during long-term amiodarone treatment.
    Baerman JM; Annesley T; DiCarlo LA; Foley MK; Nicklas JM; Crevey BJ; Morady F
    Am Heart J; 1986 Apr; 111(4):644-8. PubMed ID: 3953386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation.
    Heger JJ; Prystowsky EN; Jackman WM; Naccarelli GV; Warfel KA; Rinkenberger RL; Zipes DP
    N Engl J Med; 1981 Sep; 305(10):539-45. PubMed ID: 6789201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of amiodarone on serum triiodothyronine, reverse triiodothyronine, thyroxin, and thyrotropin. A drug influencing peripheral metabolism of thyroid hormones.
    Burger A; Dinichert D; Nicod P; Jenny M; Lemarchand-Béraud T; Vallotton MB
    J Clin Invest; 1976 Aug; 58(2):255-9. PubMed ID: 783194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High incidence of clinical and subclinical toxicity associated with amiodarone treatment of refractory tachyarrhythmias.
    Anastasiou-Nana MI; Anderson JL; Nanas JN; Lutz JR; Smith RA; Anderson KP; Crapo RO; Call NB
    Can J Cardiol; 1986; 2(3):138-45. PubMed ID: 2941121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.